Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma

Cancer Letters

Volumn 168, Issue 1, 2001, Pages 57-63

  Jung, Yu Jin ^a,b   Lee, Kee Ho ^a   Choi, Dong Wook ^a   Han, Chul Ju ^a   Jeong, Sook Hyang ^a   Kim, Keun Cheol ^a   Oh, Jong Won ^c   Park, Taek Kyu ^b   Kim, Chang Min ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Konkuk University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Cyclin D1; Cyclin E; Hepatocellular carcinoma; Reciprocal expression

Indexed keywords

CYCLIN D1; CYCLIN E;

ADULT; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CYCLIN D1; CYCLIN E; DOWN-REGULATION; HUMANS; LIVER NEOPLASMS;

EID: 0035838593     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00403-7     Document Type: Article

References (35)

1. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza B.R., Roberts J.M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 257:1992;1689-1694.
2. Koff A., Cross F., Fisher A., Schumacher J., Leguellec K., Philippe M., Roberts J.M. Human cyclin E, a new cyclin that interacts with two members CDC2 gene family. Cell. 66:1991;1217-1228.
3. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
4. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:1995;2612-2624.
5. Knoblich J.A., Sauer K., Jones L., Richardson H., Saint R., Lehner C.F. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell. 77:1994;107-120.
6. Horiguchi-Yamada J., Yamada H., Nakada S., Ochi K., Nemoto T. Change of G1 cyclins, cdk2, and cyclin A during the differentiation of HL60 cells induced by TPA. Mol. Cell. Biochem. 132:1994;31-37.
7. Imoto M., Doki Y., Jiang W., Han E., Weinstein I.B. Effects of cyclin D1 overexpression on G1 progression related events. Exp. Cell Res. 236:1997;173-180.
8. Geng Y., Whoriskey W., Park M.Y., Bronson R.T., Medema R.H., Li T., Weinberg R.A., Sicinski P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell. 97:1999;767-777.
9. Spence J., Gali R.R., Dittmar G., Sherman F., Karin M., Finley D. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain. Cell. 102:2000;67-76.
10. Prall O.W., Rogan E.M., Musgrove E.A., Watts C.K., Sutherland R.L. C-myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry. Mol. Cell. Biol. 18:1998;4499-4508.
11. Jansen-Dürr P., Meichle A., Steiner P., Pagano M., Finke K., Botz J., Wessbecher J., Draetta G., Eilers M. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA. 90:1993;3685-3689.
12. Spitkovsky D., Steiner P., Lukas J., Lees E., Pagano M., Schulze A., Joswig S., Picard D., Tommasino M., Eilers M., Jansen-Dürr P. Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation. J. Virol. 68:1994;2206-2214.
13. Lukas J., Müller H., Bartkova J., Spitkovsky D., Kjerulff A.A., Jansen-Dürr P., Strasuu M., Bartek J. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125:1994;625-638.
14. Gabrea A., Bergsagel P.L., Chesi M., Shou Y., Kuehl W.M. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol. Cell. 3:1999;119-123.
15. Keyomarsi K., Pardee A.B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA. 90:1993;1112-1116.
16. Morgan R.J., Newcomb P.V., Hardwick R.H., Alderson D. Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma. Eur. J. Surg. Oncol. 25:1999;364-367.
17. Leach F.S., Elledge S.J., Sherr C.J., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 53:1993;1986-1989.
18. Okami K., Reed A.L., Cairns P., Koch W.M., Westra W.H., Wehage S., Jen J., Sidransky D. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene. 18:1999;3541-3545.
19. Keyormarsi K., O'Leary N., Molnar G., Lees E., Fingert H.J., Pardee A.B. Cyclin E, potential prognostic marker for breast cancer. Cancer Res. 54:1994;380-385.
20. Jung J.M., Bruner J.M., Ruan S., Langford L.A., Kyritsis A.P., Kobayashi T., Levin V.A., Zhang W. Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene. 11:1995;2021-2028.
21. Sambrook J., Fritsch E.F., Maniats T. Molecular Cloning: A Laboratory Manual. 1989;382-389 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Keyomarisi K., Conte D. Jr., Toyofuku W., Fox M.P. Deregulation of cyclin E in breast cancer. Oncogene. 11:1995;941-950.
23. Matsushime H., Ewen M.E., Strom D.K., Kato J.Y., Hanks S.K., Roussel M.F., Sherr C.J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell. 71:1992;323-334.
24. Akama Y., Yasui W., Yokozaki H., Kuniyasu H., Kitahara K., Ishikawa T., Tahara E. Frequent amplification of the cyclin E gene in human gastric carcinoma. Jpn. J. Cancer Res. 86:1995;617-621.
25. Marone M., Scambia G., Giannitelli C., Ferrandina G., Masciullo V., Bellacosa A., Benedetti-Panici P., Mancuso S. Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. Int. J. Cancer. 75:1998;34-39.
26. Iida H., Towatari M., Tanimoto M., Morishita Y., Kodera Y., Saito H. Overexpression of cyclin E in acute myelogenous leukemia. Blood. 90:1997;3707-3713.
27. Edmondson H.A., Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 7:1954;462-503.
28. Sewing A., Ronicke V., Burger C., Funk M., Muller R. Alternative splicing of human cyclin E. J. Cell Sci. 107:1994;581-588.
29. Mumberg D., Wick M., Burger C., Haas K., Funk M., Muller R. Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Res. 25:1997;2098-2105.
30. de Jong J.S., van Diest P.J., Michalides R.J., Baak J.P. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. Mol. Pathol. 52:1999;78-83.
31. Sofer-Levi Y., Resnitzky D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene. 13:1996;2431-2437.
32. Peng S.Y., Chou S.P., Hsu H.C. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. J. Hepatol. 29:1998;281-289.
33. Sakaguchi T., Watanabe A., Sawada H., Yamada Y., Yamashita J., Matsuda M., Nakajima M., Miwa T., Hirao T., Nakano H. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer. 82:1998;1238-1243.
34. Ito Y., Matsuura N., Sakon M., Miyoshi E., Noda K., Takeda T., Umeshita K., Nagano H., Nakamori S., Dono K., Tsujimoto M., Nakahara M., Nakao K., Taniguchi N., Monden M. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology. 30:1999;90-99.
35. Fukuse T., Hirata T., Naiki H., Hitomi S., Wada H. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Res. 60:2000;242-244.